Literature DB >> 26719266

Tumor Suppressor Interferon-Regulatory Factor 1 Counteracts the Germinal Center Reaction Driven by a Cancer-Associated Gammaherpesvirus.

Wadzanai P Mboko1, Horatiu Olteanu2, Avijit Ray3, Gang Xin3, Eric J Darrah1, Suresh N Kumar4, Joseph M Kulinski1, Weiguo Cui3, Bonnie N Dittel3, Stephen B Gauld5, Vera L Tarakanova6.   

Abstract

UNLABELLED: Gammaherpesviruses are ubiquitous pathogens that are associated with the development of B cell lymphomas. Gammaherpesviruses employ multiple mechanisms to transiently stimulate a broad, polyclonal germinal center reaction, an inherently mutagenic stage of B cell differentiation that is thought to be the primary target of malignant transformation in virus-driven lymphomagenesis. We found that this gammaherpesvirus-driven germinal center expansion was exaggerated and lost its transient nature in the absence of interferon-regulatory factor 1 (IRF-1), a transcription factor with antiviral and tumor suppressor functions. Uncontrolled and persistent expansion of germinal center B cells led to pathological changes in the spleens of chronically infected IRF-1-deficient animals. Additionally, we found decreased IRF-1 expression in cases of human posttransplant lymphoproliferative disorder, a malignant condition associated with gammaherpesvirus infection. The results of our study define an unappreciated role for IRF-1 in B cell biology and provide insight into the potential mechanism of gammaherpesvirus-driven lymphomagenesis. IMPORTANCE: Gammaherpesviruses establish lifelong infection in most adults and are associated with B cell lymphomas. While the infection is asymptomatic in many hosts, it is critical to identify individuals who may be at an increased risk of virus-induced cancer. Such identification is currently impossible, as the host risk factors that predispose individuals toward viral lymphomagenesis are poorly understood. The current study identifies interferon-regulatory factor 1 (IRF-1) to be one of such candidate host factors. Specifically, we found that IRF-1 enforces long-term suppression of an inherently mutagenic stage of B cell differentiation that gammaherpesviruses are thought to target for transformation. Correspondingly, in the absence of IRF-1, chronic gammaherpesvirus infection induced pathological changes in the spleens of infected animals. Further, we found decreased IRF-1 expression in human gammaherpesvirus-induced B cell malignancies.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26719266      PMCID: PMC4810652          DOI: 10.1128/JVI.02774-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells.

Authors:  K E Weck; S S Kim; I V Virgin HW; S H Speck
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Complete sequence and genomic analysis of murine gammaherpesvirus 68.

Authors:  H W Virgin; P Latreille; P Wamsley; K Hallsworth; K E Weck; A J Dal Canto; S H Speck
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  B cells regulate murine gammaherpesvirus 68 latency.

Authors:  K E Weck; S S Kim; I V Virgin HW; S H Speck
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53.

Authors:  H Nozawa; E Oda; K Nakao; M Ishihara; S Ueda; T Yokochi; K Ogasawara; Y Nakatsuru; S Shimizu; Y Ohira; K Hioki; S Aizawa; T Ishikawa; M Katsuki; T Muto; T Taniguchi; N Tanaka
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

5.  Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage.

Authors:  N Tanaka; M Ishihara; M S Lamphier; H Nozawa; T Matsuyama; T W Mak; S Aizawa; T Tokino; M Oren; T Taniguchi
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

6.  Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri.

Authors:  S Efstathiou; Y M Ho; S Hall; C J Styles; S D Scott; U A Gompels
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

7.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

8.  Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice.

Authors:  G Yamada; M Ogawa; K Akagi; H Miyamoto; N Nakano; S Itoh; J Miyazaki; S Nishikawa; K Yamamura; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

9.  An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes.

Authors:  T Tamura; M Ishihara; M S Lamphier; N Tanaka; I Oishi; S Aizawa; T Matsuyama; T W Mak; S Taki; T Taniguchi
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

10.  Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription.

Authors:  J C Zimring; S Goodbourn; M K Offermann
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more
  12 in total

1.  B Cell-Intrinsic Expression of Interferon Regulatory Factor 1 Supports Chronic Murine Gammaherpesvirus 68 Infection.

Authors:  C N Jondle; K E Johnson; A A Uitenbroek; P A Sylvester; C Nguyen; W Cui; V L Tarakanova
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  B Cell-Specific Expression of Ataxia-Telangiectasia Mutated Protein Kinase Promotes Chronic Gammaherpesvirus Infection.

Authors:  Eric J Darrah; Joseph M Kulinski; Wadzanai P Mboko; Gang Xin; Laurent P Malherbe; Stephen B Gauld; Weiguo Cui; Vera L Tarakanova
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 3.  Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.

Authors:  Marni S Crow; Krystal K Lum; Xinlei Sheng; Bokai Song; Ileana M Cristea
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

Review 4.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

5.  Interferon Regulatory Factor 1 and Type I Interferon Cooperate To Control Acute Gammaherpesvirus Infection.

Authors:  Wadzanai P Mboko; Michaela M Rekow; Mitchell P Ledwith; Philip T Lange; Kaitlin E Schmitz; Sean Anderson; Vera L Tarakanova
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 6.  Gammaherpesviruses and B Cells: A Relationship That Lasts a Lifetime.

Authors:  Kaitlin E Johnson; Vera L Tarakanova
Journal:  Viral Immunol       Date:  2020-01-08       Impact factor: 2.257

7.  Conserved Gammaherpesvirus Protein Kinase Selectively Promotes Irrelevant B Cell Responses.

Authors:  Eric J Darrah; Christopher N Jondle; Kaitlin E Johnson; Gang Xin; Philip T Lange; Weiguo Cui; Horatiu Olteanu; Vera L Tarakanova
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

8.  T Cell-Intrinsic Interleukin 17 Receptor A Signaling Supports the Establishment of Chronic Murine Gammaherpesvirus 68 Infection.

Authors:  C N Jondle; V L Tarakanova
Journal:  J Virol       Date:  2022-06-27       Impact factor: 6.549

9.  Tumor suppressor Interferon Regulatory Factor 1 selectively blocks expression of endogenous retrovirus.

Authors:  K P Stoltz; C N Jondle; K Pulakanti; P A Sylvester; R Urrutia; S Rao; V L Tarakanova
Journal:  Virology       Date:  2018-10-17       Impact factor: 3.616

10.  T Cell-Intrinsic Interferon Regulatory Factor 1 Expression Suppresses Differentiation of CD4+ T Cell Populations That Support Chronic Gammaherpesvirus Infection.

Authors:  C N Jondle; K E Johnson; W P Mboko; V L Tarakanova
Journal:  J Virol       Date:  2021-08-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.